openPR Logo
Press release

Leprosy Treatment Market to Reap Excessive Revenues by 2028(Based on drug class type, the global leprosy treatment market is segmented as: Antibacterial Leprostatics Antitubercular Others)

04-10-2019 09:23 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Leprosy Treatment Market to Reap Excessive Revenues

Leprosy is a chronic infectious disease caused by Mycobacterium leprae. Leprosy is also known as Hansen’s disease. It affects the skin, mucosal surfaces of the upper respiratory tract, the peripheral nerves and the eyes. Leprosy can occur in people of all ages, from infants to the elderly. The exact transmission of the disease is not known, but it is strongly believed that leprosy is transferred from a leprosy patient to a healthy person. Delayed diagnosis of leprosy is likely to cause some serious complications such as muscle weakness, erectile dysfunction, kidney failure, blindness and others. The best way to prevent leprosy is to avoid contact with infected and untreated people. Leprosy is a curable disease and various drugs are available in the market for the treatment of leprosy. One of the treatments for leprosy is Multidrug Therapy (MDT), which involves the use of a combination of drugs. The World Health Organization recommends a combination of rifampicin, clofazimine and dapsone drugs for leprosy treatment.

Leprosy Treatment Market: Drivers and Restraints

Increasing prevalence of skin diseases is the primary factor expected to drive the leprosy treatment market over the forecast period. The prevalence of skin diseases, such as leprosy and psoriasis, has become common in some of the counties of Asia-Pacific, which is responsible for the robust growth of the market. Rising government initiatives and favourable reimbursement scenario for these treatments is expected to propel the leprosy treatment market. On other hand, the high cost of drugs and lack of awareness among people is expected to restrain market growth to a certain extent. In addition, the stringent regulatory requirements of FDA for the approval of drugs is also expected to be responsible for the sluggish growth of the leprosy treatment market over the forecast period.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=1304

Leprosy Treatment Market: Segmentation

The global leprosy treatment market can be segmented on the basis of drug class, distribution channel and geography.

Based on drug class type, the global leprosy treatment market is segmented as:

Antibacterial
Leprostatics
Antitubercular
Others
Based on route of administration, the global leprosy treatment market is segmented as:

Oral
Injectable
Topical
Based on distribution channel, the global leprosy treatment market is segmented as:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1304

Leprosy Treatment Market: Overview

Leprosy Treatment market is expected to witness exponential growth over the forecast period owing rising patient pool of leprosy in Asia-Pacific. According to WHO, the prevalence of this disease in 2015 was 176 cases per 10000 people. About 60% of the world’s leprosy patients live in India. Therefore, India is a major market worldwide for the treatment of this disease. Antibacterial drugs are commonly prescribed by physicians for leprosy treatment, therefore, by drugs class, the antibacterial segment is expected to gain maximum market share over the forecast period. The most common antibacterial drugs prescribed for leprosy treatment are dapsone, rifampin, clofazimine, ofloxacin and minocycline. Among distribution channels, online pharmacies is the fastest-growing segment due to the increasing adoption of e-commerce throughout the globe.

Leprosy Treatment Market: Regional Outlook

Geographically, the global leprosy treatment market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). Asia-Pacific is expected to gain maximum market share in terms of revenue owing to the high patient pool of leprosy in India and China. The APEJ is followed by Japan and Latin America owing to increasing awareness among patients about leprosy treatment options available in these regions. MEA is expected to grow at a faster rate as compared to other regions due to rising government initiatives for the treatment of this disease. North America, Western Europe and Eastern Europe are the least lucrative markets for leprosy treatment as a very small number of patients in these regions suffer from this disease owing to high standards of living and increased personal hygiene.

Leprosy Treatment Market: Key Players

Some of the key players operating in the global leprosy treatment market are Pfizer Inc., Bristol-Myers Squibb and Company, Eli Lily and Company, Johnson & Johnson Services Inc., GlaxoSmithKline PLC, Bayer AG, Cadila Pharmaceuticals, Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals and Merck & Co., Inc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Report Analysis@ https://www.factmr.com/report/1304/leprosy-treatment-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leprosy Treatment Market to Reap Excessive Revenues by 2028(Based on drug class type, the global leprosy treatment market is segmented as: Antibacterial Leprostatics Antitubercular Others) here

News-ID: 1696883 • Views: 160

More Releases from Fact.MR

Sea Biscuits Market Report with Executive Summary, Introduction, Sizing, Analysi …
The New Report "Sea Biscuits Market" published by Fact.MR, covers the competitive landscape analysis and its growth prospects over the coming years. An in-depth study of some new and prominent industry trends, analysis of engagement, and regional analysis that is very detailed have been included in the report of the Sea Biscuits market for the analysis period of 2021 – 2031. Get In-depth Insights Request for Sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=4879 Through the
Algae Omega 3 Market 2031 Report Studied by Focusing on Top Companies like: Arch …
The New Report "Algae Omega 3 Market" published by Fact.MR, covers the competitive landscape analysis and its growth prospects over the coming years. An in-depth study of some new and prominent industry trends, analysis of engagement, and regional analysis that is very detailed have been included in the report of the Algae Omega 3 market for the analysis period of 2021 – 2031. Get In-depth Insights Request for Sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=3903
Silicon Tuners Market to Record CAGR of 7% and Increase in Revenue by 2031 | Fac …
The New Report "Silicon Tuners Market" published by Fact.MR, covers the competitive landscape analysis and its growth prospects over the coming years. An in-depth study of some new and prominent industry trends, analysis of engagement, and regional analysis that is very detailed have been included in the report of the Silicon Tuners market for the analysis period of 2021 – 2031. Get In-depth Insights Request for Sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=6425 Through the
Liquid Propellants Market Disclosing Latest Advancement and Analysis of the Impa …
The New Report "Liquid Propellants Market" published by Fact.MR, covers the competitive landscape analysis and its growth prospects over the coming years. An in-depth study of some new and prominent industry trends, analysis of engagement, and regional analysis that is very detailed have been included in the report of the Liquid Propellants market for the analysis period of 2021 – 2031. Get In-depth Insights Request for Sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=6413 Through the

All 5 Releases


More Releases for Leprosy

Leprosy Treatment Market Opportunity Analysis, 2018-2026
Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk
Global Leprosy Treatment Market Industry Trend and Forecast 2025
This report focuses on the global Leprosy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leprosy Treatment development in United States, Europe and China. Leprosy, also known as Hansen's disease (HD), is a long-term infection by the bacterium Mycobacterium leprae or Mycobacterium lepromatosis. Initially, infections are without symptoms and typically remain this way for 5 to 20 years. Symptoms that develop
Leprosy Treatment Market Positive long-term growth outlook 2018-2026
Leprosy Treatment Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Leprosy Treatment market research report is a professional and in-depth study on the current state of Leprosy Treatment Industry. The Leprosy Treatment Market research report covers the present scenario and the growth prospects of
Leprosy Vaccines Market Promising Growth Opportunities over 2018 to 2028
Leprosy is chronic infectious disease caused by Mycobacterium leprae. Leprosy is also referred to as Hansen’s disease. Leprosy affects the skin, mucosal surfaces of the upper respiratory tract, the peripheral nerves and the eyes. Leprosy can occur to the people of all ages from infant to geriatric. The exact reason for transmission of leprosy is not known but it is strongly believed that leprosy is transferred from a leprosy patient
Leprosy Treatment Market Research Report by Regional Analysis : forecast 2024
Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk
Leprosy Treatment Market - Global industry analysis and forecast 2016-2024
Leprosy Treatment Market Future Outlook: Asia Pacific to be Key Growth Market Leprosy has been endemic to mankind since many decades. This needed interference of various governments around the world as well as the World Health Organization. Governments play an important role in the leprosy treatment market. Ever since the introduction of multidrug therapy by WHO in 1982, governments around the world have adopted this treatment procedure on a large scale.